Opioid Receptor Models — Baufista, Aslier, and Carjjenter 



117 



T. Hoversten, H. I. Mosberg, S. J. Watson, and H. Akil. 

 1997. Key residues defining the mu-opioid receptor 

 binding pocket: a site-directed mutagenesis study. J. 

 Neurochem. 68:344-353. 

 MOE. 2003. Chemical Computing Croup. Montreal, Can- 

 ada. 



NCBI. 2004. National Center for Biotechnology and In- 

 formation. National Institutes of Health and National 

 Library of Medicine [cited 10-21-2004 2004], Available 

 from http ://www. ncbi . nlm . nih . gov/. 



Palczewski, K., T. Kumasaka, T. Horf, C. A. Behnke, H. 

 Motoshima, B. A. Fox, I. Le Trong, D. C. Teller, T. 

 Okada, R. E. Stemkamp, M. Yamamoto, and M. Muy- 

 ano. 2000. Crystal structure of rhodopsin: a C protein- 

 coupled receptor. Science 289:739-745. 



Parrill, A. L., D. L. Baker, D. Wang, D. ]. Fischer, J. van 

 Brocklyn, S. Spiegel, C. Tigyi, and D. L. Bautista. 2000. 

 Structural features of EDGl receptor-ligand complexes 

 revealed by computational modeling and mutagenesis. 

 Pages 330-339 in E. J. Goetzl and K. R. Lynch (eds.). 

 Lysophospholipids and eicosanoids in biology and path- 

 ophysiology, edited by E. J. Coetzl and K. R. Lynch. 

 New York Academy of Sciences, New York, NY. 



Parrill, A. L., D. Wang, D. L. Bautista, J. R. Van Brocklyn, 

 Z. Lorincz, D. J. Fischer, D. L. Baker, K. Liliom, S. 

 Spiegel, and G. Tigyi. 2000. Identification of Edgl re- 

 ceptor residues that recognize sphingosine 1 -phosphate. 

 J. Biol. Chem. 275:39379-39384. 



Pogozheva, I. D., A. L. Lomize, and H. 1. Mosberg. 1997. 

 The transmembrane 7-alpha-bvmdle of rhodopsin: dis- 

 tance geometry calculations with hydrogen bonding 

 constraints. J. Biophys. 70:1963-1985. 



Raynor, K., H. Kong, Y Chen, K. Yasuda, L. Yu, G. 1. 

 Bell, and T. Reisine. 1994. Pharmacological character- 

 ization of the cloned kappa-, delta-, and mu-opioid re- 

 ceptors. Molecular Pharmacol. 45:330-334. 



Sardar, V. M., D. L. Bautista, D. J. Fischer, K. Yokoyama, 

 N. Nusser, T. Virag, D. A. Wang, D. L. Baker, G. Tigyi, 

 and A. L. Parrill. 2002. Molecular basis for lysophos- 

 phatidic acid receptor antagonist selectivity. Biochim. 

 Biophys. Acta 1582:309-317. 



Schertler, G. F, C. Villa, and R. Henderson. 1993. Pro- 

 jection structure of rhodopsin. Nature 362:770-772. 



Stevens, C. W. 1994. Perspectives on opioid tolerance 

 from basic research: behavioral studies after spinal ad- 

 ministration in rodents. Cancer Sur\/. 21:25-47. 



Strahs, D., and H. Weinstein. 1997. Comparative model- 

 ing and molecular dynamics studies of the delta, kappa 

 and mu opioid receptors. Protein Engin. 10:1019-1038. 



van Rhee, A. M., and K. A. Jacobson. 1996. Molecular 

 architecture of G protein-coupled receptors. Drug Dev. 

 Res. 37:1-38. 



Wang, D. A., Z. Lorincz, D. L. Bautista, K. Liliom, G. 

 Tigyi, and A. L. Parrill. 2001. A single amino acid de- 

 termines lysophospholipid specificity of the SlPl 

 (EDGl) and LPAl (EDG2) phospholipid growth factor 

 receptors. J. Biol. Chem. 276:49213-49220. 



1 



